Clinical Report: Challenges and Advances in Obesity Care

Overview

Obesity care faces significant barriers despite advances in treatment options. Key challenges include reliance on BMI for diagnosis, underuse of staging systems, limited access to therapies, and pervasive stigma affecting care delivery.

Background

Obesity is a chronic, heterogeneous disease influenced by biological drivers such as gut hormones and central nervous system pathways. Although treatment options like pharmacotherapy, surgery, and lifestyle interventions have expanded, only a small proportion of eligible patients receive these therapies. Stigma remains widespread, impacting both patients and healthcare providers, and contributes to fragmented care pathways that do not reflect the chronic nature of obesity. Economic analyses highlight obesity's broader impact on national productivity, underscoring the need for improved management strategies.

Data Highlights

Key Findings

• 88% of individuals with obesity report stigma, reproval, or abuse related to their condition.
• Current obesity care relies heavily on BMI, which inadequately captures disease severity.
• Staging systems like the Edmonton Obesity Staging System are underutilized despite better predicting outcomes.
• Access to effective treatments such as pharmacotherapy, surgery, and intensive lifestyle interventions remains limited.
• Obesity care is often fragmented and short-term, failing to address its chronic nature.
• Recent data suggest a decline in US adult obesity prevalence from 40% in 2022 to 37% in 2025, coinciding with increased anti-obesity medication use, though causation is unclear.

Clinical Implications

Clinicians should move beyond BMI as the sole diagnostic tool and incorporate staging systems to better assess disease severity and guide individualized treatment. Recognizing obesity as a chronic disease necessitates long-term management strategies focused on complications and risk profiles rather than weight alone. Efforts to reduce stigma within healthcare settings are essential to improve patient engagement and outcomes.

Conclusion

Advances in obesity treatment have not yet translated into widespread improvements in care due to systemic barriers and persistent stigma. Progress will require adopting chronic disease management models with individualized, long-term approaches supported by improved diagnostic and staging tools.

References

1. Miras et al. 2024 -- Obesity Care Lags Behind Advances in Treatment